American Heart Association seeks a Cure for Coronary Heart Disease And Its Devastating Consequences
January 17, 2016
Applications open to find a single Leader and Team for $75M bold new research approach
Dallas, TX – The American Heart Association (AHA) and Verily, (formerly Google Life Sciences)has announced that AstraZeneca (AZ) has joined them in a bold new approach to find a cure for coronary heart disease and improve cardiovascular health. With a commitment of $75 million dollars over at least a five year period, the three organizations have initiated the single largest research project funding one leader and team in the fight to cure coronary heart disease.
The application period for this new research enterprise officially opened January 14th at: www.onebraveidea.com.
American Heart Association Pleased New CDC Study Shows More U.S. Adults are Putting Out Cigarettes for Good
November 21, 2015
But prevalence among uninsured and those on Medicaid raises concern
Washington, D.C. – American Heart Association CEO Nancy Brown issued the following comments on a study by the Centers for Disease Control and Prevention (CDC) published in today’s Morbidity and Mortality Weekly Report (MMWR).
The study, which examined 2014 National Health Interview Survey (NHIS) data, noted that overall adult smoking rates dropped a full percentage point between 2013 and 2014. It also reported on differences in U.S. smoking rates, including that uninsured adults or those insured through Medicaid smoke at rates twice as high as those covered by private health insurance or Medicare:
American Heart Association Editorial on E-Cigarettes
September 29, 2014
Written by Nancy Brown
Chief Executive Officer, American Heart Association
Dallas, TX – The American Heart Association recently issued new policy recommendations on the use of e-cigarettes and their impact on tobacco control efforts.
Based on the current evidence, our position is that e-cigarettes containing nicotine are tobacco products and therefore should be subject to all laws that apply to tobacco products.
Cost to treat Heart Disease in United States will triple by 2030
January 25, 2011
Dallas, TX – The cost to treat heart disease in the United States will triple by 2030, according to a policy statement published in Circulation: Journal of the American Heart Association.
“Despite the successes in reducing and treating heart disease over the last half century, even if we just maintain our current rates, we will have an enormous financial burden on top of the disease itself,” said Paul Heidenreich, M.D., chair of the American Heart Association expert panel issuing the statement.
The panel estimated future medical costs based on the current rates of disease and used Census data to adjust for anticipated population shifts in age and race. The rigorous methods they devised didn’t double count costs for patients with multiple heart conditions. [Read more]
How Tobacco Smoke Causes Disease
December 12, 2010
American Heart Association CEO Nancy Brown says U.S. Surgeon General Report Stresses Importance of Cessation Strategies to Reduce Tobacco’s Deadly Toll
The U.S. Surgeon General’s report, “How Tobacco Smoke Causes Disease,” sheds new light on the damaging effects of tobacco use on the health of all Americans.
This comprehensive scientific report shows that even brief exposure to tobacco smoke can trigger acute cardiac events and potential sudden death. The evidence clearly states that tobacco products are lethal weapons capable of shortening the lifespan of smokers and nonsmokers alike.
[youtube]http://www.youtube.com/watch?v=3EbYaJc4J2A[/youtube]










